BNA Gapmers在强直性肌营养不良细胞中可逆转剪接并减少RNA病灶，且毒性较低。
BNA Gapmers Revert Splicing and Reduce RNA Foci with Low Toxicity in Myotonic Dystrophy Cells.
作者信息
Manning Kassie S, Rao Ashish N, Castro Miguel, Cooper Thomas A
机构信息
Bio-Synthesis, Inc. , 612 East Main Street, Lewisville, Texas 75057, United States.
出版信息
ACS Chem Biol. 2017 Oct 20;12(10):2503-2509. doi: 10.1021/acschembio.7b00416. Epub 2017 Sep 5.
Abstract
Myotonic dystrophy type 1 (DM1) is a multisystemic disease caused by an expanded CTG repeat in the 3' UTR of the dystrophia myotonica protein kinase (DMPK) gene. Short, DNA-based antisense oligonucleotides termed gapmers are a promising strategy to degrade toxic CUG expanded repeat (CUG) RNA. Nucleoside analogs are incorporated to increase gapmer affinity and stability; however, some analogs also exhibit toxicity. In this study, we demonstrate that the 2',4'-BNA[NMe] (BNA) modification is a promising nucleoside analog with high potency similar to 2',4'-LNA (LNA). BNA gapmers targeting a nonrepetitive region of the DMPK 3' UTR show allele-specific knockdown of CUG RNA and revert characteristic DM1 molecular defects including mis-splicing and accumulation of RNA foci. Notably, the BNA gapmers tested in this study did not induce caspase activation, in contrast to a sequence matched LNA gapmer. This study indicates that BNA gapmers warrant further study as a promising RNA targeting therapeutic.
摘要
1型强直性肌营养不良症（DM1）是一种多系统疾病，由肌强直性营养不良蛋白激酶（DMPK）基因3'非翻译区的CTG重复序列扩增引起。短的、基于DNA的反义寡核苷酸（称为gapmer）是降解有毒CUG扩增重复序列（CUG）RNA的一种有前景的策略。掺入核苷类似物以增加gapmer的亲和力和稳定性；然而，一些类似物也表现出毒性。在本研究中，我们证明2'，4'-BNA[NMe]（BNA）修饰是一种有前景的核苷类似物，其效力与2'，4'-锁核酸（LNA）相似。靶向DMPK 3'非翻译区非重复区域的BNA gapmer显示CUG RNA的等位基因特异性敲低，并逆转包括剪接错误和RNA病灶积累在内的特征性DM1分子缺陷。值得注意的是，与序列匹配的LNA gapmer相比，本研究中测试的BNA gapmer未诱导半胱天冬酶激活。本研究表明，BNA gapmer作为一种有前景的RNA靶向治疗药物值得进一步研究。
相似文献
1
BNA Gapmers Revert Splicing and Reduce RNA Foci with Low Toxicity in Myotonic Dystrophy Cells.BNA Gapmers在强直性肌营养不良细胞中可逆转剪接并减少RNA病灶，且毒性较低。
ACS Chem Biol. 2017 Oct 20;12(10):2503-2509. doi: 10.1021/acschembio.7b00416. Epub 2017 Sep 5.
2
AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1.AON 诱导的剪接转换和 DMPK pre-mRNA 降解作为 1 型肌强直性营养不良的潜在治疗方法。
Nucleic Acids Res. 2020 Mar 18;48(5):2531-2543. doi: 10.1093/nar/gkaa007.
3
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.短反义锁核酸（全锁核酸）可纠正强直性肌营养不良中的异常剪接。
Nucleic Acids Res. 2015 Mar 31;43(6):3318-31. doi: 10.1093/nar/gkv163. Epub 2015 Mar 9.
4
Systemic Evaluation of Chimeric LNA/2'-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy.肌强直性营养不良 1 型治疗的嵌合 LNA/2'-O-甲基位阻物的系统评价。
Nucleic Acid Ther. 2020 Apr;30(2):80-93. doi: 10.1089/nat.2019.0811. Epub 2019 Dec 23.
5
Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.在发育过程中，有义链和反义链 DMPK RNA 病灶在 DM1 组织中积累。
PLoS One. 2015 Sep 4;10(9):e0137620. doi: 10.1371/journal.pone.0137620. eCollection 2015.
6
Degradation of Toxic RNA in Myotonic Dystrophy Using Gapmer Antisense Oligonucleotides.使用 Gapmer 反义寡核苷酸降解肌强直性营养不良中的毒性 RNA。
Methods Mol Biol. 2020;2176:99-109. doi: 10.1007/978-1-0716-0771-8_7.
7
Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1.在小鼠和非人灵长类动物中鉴定和表征靶向强直性肌营养不良蛋白激酶（DMPK）的修饰反义寡核苷酸用于治疗1型强直性肌营养不良症
J Pharmacol Exp Ther. 2015 Nov;355(2):329-40. doi: 10.1124/jpet.115.226969. Epub 2015 Sep 1.
8
Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.肌强直性营养不良中，肌盲蛋白与RNA病灶的共定位与可变剪接的失调是可分离的。
J Cell Sci. 2005 Jul 1;118(Pt 13):2923-33. doi: 10.1242/jcs.02404. Epub 2005 Jun 16.
9
Expanded CUG repeats in transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences.转录本中的扩展 CUG 重复形成多种发夹构象，而不影响侧翼序列的结构。
RNA. 2019 Apr;25(4):481-495. doi: 10.1261/rna.068940.118. Epub 2019 Jan 30.
10
Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA.在一种RNA毒性小鼠模型中，采用靶向DMPK 3'UTR RNA中非CUG序列的反义寡核苷酸疗法进行全身治疗。
Hum Mol Genet. 2020 Jun 3;29(9):1440-1453. doi: 10.1093/hmg/ddaa060.
引用本文的文献
1
Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity.永生化的1型强直性肌营养不良症人类肌肉细胞系，用于解决患者异质性问题。
iScience. 2024 May 7;27(6):109930. doi: 10.1016/j.isci.2024.109930. eCollection 2024 Jun 21.
2
Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo.自递呈的、化学修饰的 CRISPR RNA 用于 AAV 共递送和体内基因组编辑。
Nucleic Acids Res. 2024 Jan 25;52(2):977-997. doi: 10.1093/nar/gkad1125.
3
Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1.1 型肌强直性营养不良反义疗法的研究进展与挑战
Int J Mol Sci. 2022 Nov 1;23(21):13359. doi: 10.3390/ijms232113359.
4
Mechanistic and Therapeutic Insights into Ataxic Disorders with Pentanucleotide Expansions.五核苷酸重复扩展相关共济失调障碍的发病机制和治疗学新见解。
Cells. 2022 May 6;11(9):1567. doi: 10.3390/cells11091567.
5
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1.1型强直性肌营养不良症的脑发病机制及潜在治疗策略
Front Aging Neurosci. 2021 Nov 15;13:755392. doi: 10.3389/fnagi.2021.755392. eCollection 2021.
6
Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells.利用合成工程化引导RNA增强哺乳动物细胞中的CRISPR基因组编辑系统。
Front Genome Ed. 2021 Jan 28;2:617910. doi: 10.3389/fgeed.2020.617910. eCollection 2020.
7
A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1.一种基于CRISPR-Cas13a的策略，用于追踪和降解1型强直性肌营养不良中的毒性RNA。
Front Genet. 2020 Dec 10;11:594576. doi: 10.3389/fgene.2020.594576. eCollection 2020.
8
AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1.AON 诱导的剪接转换和 DMPK pre-mRNA 降解作为 1 型肌强直性营养不良的潜在治疗方法。
Nucleic Acids Res. 2020 Mar 18;48(5):2531-2543. doi: 10.1093/nar/gkaa007.
9
Bridged Nucleic Acids Reloaded.桥连核酸再激活。
Molecules. 2019 Jun 21;24(12):2297. doi: 10.3390/molecules24122297.
10
Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity.将桥连核酸整合到 CRISPR RNA 中可提高 Cas9 内切酶的特异性。
Nat Commun. 2018 Apr 13;9(1):1448. doi: 10.1038/s41467-018-03927-0.
本文引用的文献
1
Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice.Dmpk基因缺失或反义敲低不会损害小鼠的心脏或骨骼肌功能。
Hum Mol Genet. 2016 Oct 1;25(19):4328-4338. doi: 10.1093/hmg/ddw266. Epub 2016 Aug 13.
2
Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.锁核酸修饰的gapmer反义寡核苷酸引起的核糖核酸酶H1依赖性肝毒性。
Sci Rep. 2016 Jul 27;6:30377. doi: 10.1038/srep30377.
3
Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.热休克蛋白90（Hsp90）与含有疏水性2'-修饰的硫代磷酸酯寡核苷酸相互作用，并增强反义活性。
Nucleic Acids Res. 2016 May 5;44(8):3892-907. doi: 10.1093/nar/gkw144. Epub 2016 Mar 3.
4
A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.低绝对数量的扩增转录本参与了1型强直性肌营养不良症在肌肉中的表现。
Hum Mol Genet. 2016 Apr 15;25(8):1648-62. doi: 10.1093/hmg/ddw042. Epub 2016 Feb 16.
5
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.高亲和力缺口mer反义寡核苷酸的肝毒性是由RNase H1依赖性的超长前体mRNA转录本的混杂减少介导的。
Nucleic Acids Res. 2016 Mar 18;44(5):2093-109. doi: 10.1093/nar/gkv1210. Epub 2015 Nov 8.
6
In silico and in vitro evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization.通过计算机模拟和体外实验评估外显子和内含子的脱靶效应是治疗性 ASO 寡核苷酸优化的关键要素。
Nucleic Acids Res. 2015 Oct 15;43(18):8638-50. doi: 10.1093/nar/gkv857. Epub 2015 Sep 3.
7
Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.鉴定和表征与硫代磷酸酯键连接的寡核苷酸结合的细胞内蛋白质。
Nucleic Acids Res. 2015 Mar 11;43(5):2927-45. doi: 10.1093/nar/gkv143. Epub 2015 Feb 20.
8
Myotonic dystrophy.肌强直性营养不良症。
Neurol Clin. 2014 Aug;32(3):705-19, viii. doi: 10.1016/j.ncl.2014.04.011. Epub 2014 Jun 6.
9
The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression.Mef2转录网络在强直性肌营养不良心脏组织中被破坏，极大地改变了miRNA和mRNA的表达。
Cell Rep. 2014 Jan 30;6(2):336-45. doi: 10.1016/j.celrep.2013.12.025. Epub 2014 Jan 9.
10
Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice.锁核酸反义寡核苷酸的肝转录谱比较：非靶介导毒性在小鼠中相关途径的证据。
Toxicol Sci. 2014 Mar;138(1):234-48. doi: 10.1093/toxsci/kft278. Epub 2013 Dec 11.
Zotero 插件